Cardiac lipid content is unresponsive to a physical activity training intervention in type 2 diabetic patients, despite improved ejection fraction

Cardiovascular Diabetology

Volumn 10, Issue , 2011, Pages

  Schrauwen Hinderling, Vera B ^a,b   Meex, Ruth C R ^a,b,c   Hesselink, Matthijs K C ^a,b   van de Weijer, Tineke ^a,b   Leiner, Tim ^b,d,e   Schär, Michael ^f,g   Lamb, Hildo J ^h   Wildberger, Joachim E ^b   Glatz, Jan F C ^b,d   Schrauwen, Patrick ^a,b   Kooi, M Eline ^a,b,d  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^c MONASH UNIVERSITY   (Australia)

^d MAASTRICHT UNIVERSITY   (Netherlands)

^e UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^f JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g PHILIPS HEALTHCARE   (United States)

^h LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Cardiomyopathy; Ectopic fattype 2 diabetes mellitus; Exercise; Lipotoxicity; Magnetic resonance imaging; Magnetic resonance spectroscopy

Indexed keywords

LIPID;

ARTICLE; CARDIOVASCULAR RISK; CINERADIOGRAPHY; DIABETIC PATIENT; ENDURANCE TRAINING; EXERCISE; HEART; HEART EJECTION FRACTION; HEART FUNCTION; HUMAN; INSULIN SENSITIVITY; LIPID ANALYSIS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; OXYGEN CONSUMPTION; PHYSICAL ACTIVITY; PROTON NUCLEAR MAGNETIC RESONANCE; TISSUE LEVEL; BODY WEIGHT; CONVALESCENCE; DIABETIC CARDIOMYOPATHY; GLUCOSE CLAMP TECHNIQUE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE; HEART STROKE VOLUME; INSULIN RESISTANCE; LIPID METABOLISM; METABOLISM; MIDDLE AGED; NETHERLANDS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOPHYSIOLOGY; RESISTANCE TRAINING; TIME; TREATMENT OUTCOME;

ADIPOSITY; BODY WEIGHT; DIABETES MELLITUS, TYPE 2; DIABETIC CARDIOMYOPATHIES; GLUCOSE CLAMP TECHNIQUE; HUMANS; INSULIN RESISTANCE; LIPID METABOLISM; MAGNETIC RESONANCE IMAGING, CINE; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; MYOCARDIUM; NETHERLANDS; OVERWEIGHT; OXYGEN CONSUMPTION; RECOVERY OF FUNCTION; RESISTANCE TRAINING; STROKE VOLUME; TIME FACTORS; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT;

EID: 79957453372     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-10-47     Document Type: Article

References (33)

1. Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, De Simone G, Ferguson TB, Ford E, Furie K, Gillespie C, et al. Heart disease and stroke statistics--2010 update: a report from the American Heart Association. Circulation 2010, 121:e46-e215.
2. Bibbins-Domingo K, Lin F, Vittinghoff E, Barrett-Connor E, Hulley SB, Grady D, Shlipak MG. Predictors of heart failure among women with coronary disease. Circulation 2004, 110:1424-1430. 10.1161/01.CIR.0000141726.01302.83, 15353499.
3. Yagyu H, Chen G, Yokoyama M, Hirata K, Augustus A, Kako Y, Seo T, Hu Y, Lutz EP, Merkel M, et al. Lipoprotein lipase (LpL) on the surface of cardiomyocytes increases lipid uptake and produces a cardiomyopathy. J Clin Invest 2003, 111:419-426. 151861, 12569168.
4. Chiu HC, Kovacs A, Ford DA, Hsu FF, Garcia R, Herrero P, Saffitz JE, Schaffer JE. A novel mouse model of lipotoxic cardiomyopathy. J Clin Invest 2001, 107:813-822. 10.1172/JCI10947, 199569, 11285300.
5. Cheng L, Ding G, Qin Q, Huang Y, Lewis W, He N, Evans RM, Schneider MD, Brako FA, Xiao Y, et al. Cardiomyocyte-restricted peroxisome proliferator-activated receptor-delta deletion perturbs myocardial fatty acid oxidation and leads to cardiomyopathy. Nat Med 2004, 10:1245-1250. 10.1038/nm1116, 15475963.
6. Nielsen LB, Bartels ED, Bollano E. Overexpression of apolipoprotein B in the heart impedes cardiac triglyceride accumulation and development of cardiac dysfunction in diabetic mice. J Biol Chem 2002, 277:27014-27020. 10.1074/jbc.M203458200, 12015323.
7. Lee Y, Naseem RH, Duplomb L, Park BH, Garry DJ, Richardson JA, Schaffer JE, Unger RH. Hyperleptinemia prevents lipotoxic cardiomyopathy in acyl CoA synthase transgenic mice. Proc Natl Acad Sci USA 2004, 101:13624-13629. 10.1073/pnas.0405499101, 518804, 15347805.
8. McGavock JM, Lingvay I, Zib I, Tillery T, Salas N, Unger R, Levine BD, Raskin P, Victor RG, Szczepaniak LS. Cardiac steatosis in diabetes mellitus: a 1H-magnetic resonance spectroscopy study. Circulation 2007, 116:1170-1175. 10.1161/CIRCULATIONAHA.106.645614, 17698735.
9. Rijzewijk LJ, van der Meer RW, Smit JW, Diamant M, Bax JJ, Hammer S, Romijn JA, de Roos A, Lamb HJ. Myocardial steatosis is an independent predictor of diastolic dysfunction in type 2 diabetes mellitus. J Am Coll Cardiol 2008, 52:1793-1799. 10.1016/j.jacc.2008.07.062, 19022158.
10. Kankaanpaa M, Lehto HR, Parkka JP, Komu M, Viljanen A, Ferrannini E, Knuuti J, Nuutila P, Parkkola R, Iozzo P. Myocardial triglyceride content and epicardial fat mass in human obesity: relationship to left ventricular function and serum free fatty acid levels. J Clin Endocrinol Metab 2006, 91:4689-4695. 10.1210/jc.2006-0584, 16926257.
11. Szczepaniak LS, Dobbins RL, Metzger GJ, Sartoni-D'Ambrosia G, Arbique D, Vongpatanasin W, Unger R, Victor RG. Myocardial triglycerides and systolic function in humans: in vivo evaluation by localized proton spectroscopy and cardiac imaging. Magn Reson Med 2003, 49:417-423. 10.1002/mrm.10372, 12594743.
12. van der Meer RW, Doornbos J, Kozerke S, Schar M, Bax JJ, Hammer S, Smit JW, Romijn JA, Diamant M, Rijzewijk LJ, et al. Metabolic imaging of myocardial triglyceride content: reproducibility of 1H MR spectroscopy with respiratory navigator gating in volunteers. Radiology 2007, 245:251-257. 10.1148/radiol.2451061904, 17885193.
13. Gu K, Cowie CC, Harris MI. Mortality in adults with and without diabetes in a national cohort of the U.S. population, 1971-1993. Diabetes Care 1998, 21:1138-1145. 10.2337/diacare.21.7.1138, 9653609.
14. Schrauwen-Hinderling VB, Hesselink MK, Meex R, van der Made S, Schar M, Lamb H, Wildberger JE, Glatz J, Snoep G, Kooi ME, Schrauwen P. Improved ejection fraction after exercise training in obesity is accompanied by reduced cardiac lipid content. J Clin Endocrinol Metab 2010, 95:1932-1938. 10.1210/jc.2009-2076, 20173015.
15. Buse JB, Ginsberg HN, Bakris GL, Clark NG, Costa F, Eckel R, Fonseca V, Gerstein HC, Grundy S, Nesto RW, et al. Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association. Diabetes Care 2007, 30:162-172. 10.2337/dc07-9917, 17192355.
16. Siri W. The gross composition of the body. Adv Biol Med Physiol 1956, 4:239-280.
17. Vanhamme L, van den Boogaart A, Van Huffel S. Improved method for accurate and efficient quantification of MRS data with use of prior knowledge. J Magn Reson 1997, 129:35-43. 10.1006/jmre.1997.1244, 9405214.
18. Naressi A, Couturier C, Devos JM, Janssen M, Mangeat C, de Beer R, Graveron-Demilly D. Java-based graphical user interface for the MRUI quantitation package. Magma 2001, 12:141-152. 10.1007/BF02668096, 11390270.
19. Colberg SR, Sigal RJ, Fernhall B, Regensteiner JG, Blissmer BJ, Rubin RR, Chasan-Taber L, Albright AL, Braun B. Exercise and type 2 diabetes: the American College of Sports Medicine and the American Diabetes Association: joint position statement executive summary. Diabetes Care 2010, 33:2692-2696. 10.2337/dc10-1548, 21115771.
20. Balducci S, Zanuso S, Nicolucci A, De Feo P, Cavallo S, Cardelli P, Fallucca S, Alessi E, Fallucca F, Pugliese G. Effect of an intensive exercise intervention strategy on modifiable cardiovascular risk factors in subjects with type 2 diabetes mellitus: a randomized controlled trial: the Italian Diabetes and Exercise Study (IDES). Arch Intern Med 2010, 170:1794-1803. 10.1001/archinternmed.2010.380, 21059972.
21. Monteiro LZ, Fiani CR, Freitas MC, Zanetti ML, Foss MC. Decrease in blood pressure, body mass index and glycemia after aerobic training in elderly women with type 2 diabetes. Arq Bras Cardiol 2010, 95:563-570. 10.1590/S0066-782X2010005000135, 20922265.
22. Okada S, Hiuge A, Makino H, Nagumo A, Takaki H, Konishi H, Goto Y, Yoshimasa Y, Miyamoto Y. Effect of exercise intervention on endothelial function and incidence of cardiovascular disease in patients with type 2 diabetes. J Atheroscler Thromb 2010, 17:828-833.
23. Leehey DJ, Moinuddin I, Bast JP, Qureshi S, Jelinek CS, Cooper C, Edwards LC, Smith BM, Collins EG. Aerobic exercise in obese diabetic patients with chronic kidney disease: a randomized and controlled pilot study. Cardiovasc Diabetol 2009, 8:62. 10.1186/1475-2840-8-62, 2796994, 20003224.
24. Miche E, Herrmann G, Nowak M, Wirtz U, Tietz M, Hurst M, Zoller B, Radzewitz A. Effect of an exercise training program on endothelial dysfunction in diabetic and non-diabetic patients with severe chronic heart failure. Clin Res Cardiol 2006, 95(Suppl 1):i117-124.
25. Loimaala A, Groundstroem K, Rinne M, Nenonen A, Huhtala H, Vuori I. Exercise training does not improve myocardial diastolic tissue velocities in Type 2 diabetes. Cardiovasc Ultrasound 2007, 5:32. 10.1186/1476-7120-5-32, 2094704, 17897465.
26. Hordern MD, Coombes JS, Cooney LM, Jeffriess L, Prins JB, Marwick TH. Effects of exercise intervention on myocardial function in type 2 diabetes. Heart 2009, 95:1343-1349. 10.1136/hrt.2009.165571, 19429570.
27. Loganathan R, Bilgen M, Al-Hafez B, Zhero SV, Alenezy MD, Smirnova IV. Exercise training improves cardiac performance in diabetes: in vivo demonstration with quantitative cine-MRI analyses. J Appl Physiol 2007, 102:665-672.
28. Korte FS, Mokelke EA, Sturek M, McDonald KS. Exercise improves impaired ventricular function and alterations of cardiac myofibrillar proteins in diabetic dyslipidemic pigs. J Appl Physiol 2005, 98:461-467.
29. Zib I, Jacob AN, Lingvay I, Salinas K, McGavock JM, Raskin P, Szczepaniak LS. Effect of pioglitazone therapy on myocardial and hepatic steatosis in insulin-treated patients with type 2 diabetes. J Investig Med 2007, 55:230-236. 10.2310/6650.2007.00003, 17850734.
30. van der Meer RW, Rijzewijk LJ, de Jong HW, Lamb HJ, Lubberink M, Romijn JA, Bax JJ, de Roos A, Kamp O, Paulus WJ, et al. Pioglitazone improves cardiac function and alters myocardial substrate metabolism without affecting cardiac triglyceride accumulation and high-energy phosphate metabolism in patients with well-controlled type 2 diabetes mellitus. Circulation 2009, 119:2069-2077. 10.1161/CIRCULATIONAHA.108.803916, 19349323.
31. Bilet L, van de Weijer T, Hesselink MK, Glatz JF, Lamb HJ, Wildberger J, Kooi ME, Schrauwen P, Schrauwen-Hinderling VB. Exercise-induced modulation of cardiac lipid content in healthy lean young men. Basic Res Cardiol 106:307-315.
32. Lahaye Sle D, Gratas-Delamarche A, Malarde L, Vincent S, Zguira MS, Morel SL, Delamarche P, Zouhal H, Carre F, Bekono FR. Intense exercise training induces adaptation in expression and responsiveness of cardiac beta-adrenoceptors in diabetic rats. Cardiovasc Diabetol 2010, 9:72. 10.1186/1475-2840-9-72, 2992048, 21054861.
33. Kemi OJ, Ellingsen O, Smith GL, Wisloff U. Exercise-induced changes in calcium handling in left ventricular cardiomyocytes. Front Biosci 2008, 13:356-368. 10.2741/2685, 17981553.